Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04552782
Other study ID # 1R01MH122954
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 4, 2020
Est. completion date April 30, 2025

Study information

Verified date May 2023
Source University of South Dakota
Contact Jeffrey S Simons, PhD
Phone 605-658-3710
Email jeffrey.simons@usd.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study seeks to increase understanding of Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD) among veterans, an important public health concern. We will study the effects of regulatory deficits and sleep disturbance on the dynamic course of PTSD and AUD. The study will investigate whether a short, computerized training in the laboratory will alter maladaptive response biases and reduce associations between sleep disturbance, affect and behavioral dysregulation, AUD symptoms, and PTSD symptoms in the real world.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date April 30, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - OIF/OEF/OND veterans - At risk for PTSD (i.e., PCL-5 =33) and/or AUD (i.e., AUDIT = 7 (women) = 8 (men)) Exclusion Criteria: - Psychosis or severe Alcohol Use Disorder that contraindicates participation (based on interview) - Active suicidal or homicidal ideation that contraindicates participation (based on interview) - [exclusion criteria removed 6/2022] - Severe risk for sleep apnea (a positive score in three categories of the Berlin Questionnaire), or reported treatment for sleep apnea

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Alcohol CBM
Trains approach or avoidance responses to alcohol cues.
PTSD CBM
Trains approach or avoidance responses to trauma cues.
Alcohol Sham
Will not train approach or avoidance responses.
PTSD Sham
Will not train approach or avoidance responses.

Locations

Country Name City State
United States Bay Pines VA Health Care System Bay Pines Florida
United States Sioux Falls VA Health Care System Sioux Falls South Dakota
United States The University of South Dakota Vermillion South Dakota

Sponsors (4)

Lead Sponsor Collaborator
University of South Dakota Bay Pines VA Healthcare System, National Institute of Mental Health (NIMH), Sioux Falls VA Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of Alcohol Use Disorder Symptoms These are experience sampling items derived from Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 2 years
Primary Rate of PTSD Symptoms These are experience sampling items derived from the PTSD Checklist from DSM-5 (PCL-5). 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05054738 - CRP and S&A for Inpatient Veterans N/A
Completed NCT02233738 - Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT00536146 - The Stress-Hormone System in Alcohol-Dependent Subjects N/A
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02939352 - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues Early Phase 1
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01389297 - Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery N/A
Completed NCT00768508 - Combined Pharmacotherapies for Alcoholism Phase 3
Completed NCT01113164 - Matching Genotypes and Serotonergic Medications for Alcoholism Phase 1
Completed NCT01760785 - Valproate for Mood Swings and Alcohol Use Following Head Injury N/A
Terminated NCT02842528 - Cognitive Vulnerability Factors in Alcohol-dependence N/A
Completed NCT00127231 - Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women N/A
Completed NCT00367575 - An Internet-based Intervention for Problem Drinking N/A
Completed NCT00167687 - Prazosin Alcohol Dependence IVR Study Phase 4
Completed NCT00583440 - 12-step Facilitation for the Dually Diagnosed Phase 1/Phase 2
Completed NCT00223639 - New Medications to Treat Alcohol Dependence Phase 2